U.S. Carrier Screening Market on the basis of Type (Expanded Carrier Screening and Targeted Disease Carrier Screening), Technology (DNA Sequencing, Polymerase Chain Reaction, Microarrays and Others) and End User (Hospitals & Clinics, Reference Laboratories, Physician Offices and Others) Forecast up to 2027
U.S. Carrier Screening Market on the basis of Type (Expanded Carrier Screening and Targeted Disease Carrier Screening), Technology (DNA Sequencing, Polymerase Chain Reaction, Microarrays and Others) and End User (Hospitals & Clinics, Reference Laboratories, Physician Offices and Others) Forecast up to 2027
- 1. Executive Summary
- 2. Industry Outlook
- 2.1. Industry Overview
- 2.2. Industry Trends
- 3. Market Snapshot
- 3.1. Market Definition
- 3.2. Market Outlook
- 3.2.1. Porter Five Forces
- 3.3. Related Markets
- 4. Market characteristics
- 4.1. Market Overview
- 4.2. Market Segmentation
- 4.3. Market Dynamics
- 4.3.1. Drivers
- 4.3.2. Restraints
- 4.3.3. Opportunities
- 4.4. DRO - Impact Analysis
- 5. Product: Market Size & Analysis
- 5.1. Overview
- 5.2. Expanded Carrier Screening
- 5.2.1. Customized Panel Testing
- 5.2.2. Predesigned Panel Testing
- 5.3. Targeted Disease Carrier Screening
- 6. Technology: Market Size & Analysis
- 6.1. Overview
- 6.2. DNA Sequencing
- 6.3. Polymerase Chain Reaction
- 6.4. Microarrays
- 6.5. Others
- 7. End User: Market Size & Analysis
- 7.1. Overview
- 7.2. Hospitals & Clinics
- 7.3. Reference Laboratories
- 7.4. Physician Offices
- 7.5. Others
- 8. Competitive Landscape
- 8.1. Competitor Comparison Analysis
- 8.2. Market Developments
- 8.2.1. Mergers and Acquisitions, Legal, Awards, Partnerships
- 8.2.2. Product Launches and execution
- 9. Vendor Profiles
- 9.1. Myriad Genetics Inc.
- 9.1.1. Overview
- 9.1.2. Financial Overview
- 9.1.3. Product Offerings
- 9.1.4. Developments
- 9.1.5. Business Strategy
- 9.2. Thermo Fisher Scientific Inc.
- 9.2.1. Overview
- 9.2.2. Financial Overview
- 9.2.3. Product Offerings
- 9.2.4. Developments
- 9.2.5. Business Strategy
- 9.3. PerkinElmer Inc.
- 9.3.1. Overview
- 9.3.2. Financial Overview
- 9.3.3. Product Offerings
- 9.3.4. Developments
- 9.3.5. Business Strategy
- 9.4. Fulgent Genetics Inc.
- 9.4.1. Overview
- 9.4.2. Financial Overview
- 9.4.3. Product Offerings
- 9.4.4. Developments
- 9.4.5. Business Strategy
- 9.5. Quest Diagnostics Incorporated
- 9.5.1. Overview
- 9.5.2. Financial Overview
- 9.5.3. Product Offerings
- 9.5.4. Developments
- 9.5.5. Business Strategy
- 9.6. Invitae Corporation
- 9.6.1. Overview
- 9.6.2. Financial Overview
- 9.6.3. Product Offerings
- 9.6.4. Developments
- 9.6.5. Business Strategy
- 9.7. Illumina Inc.
- 9.7.1. Overview
- 9.7.2. Financial Overview
- 9.7.3. Product Offerings
- 9.7.4. Developments
- 9.7.5. Business Strategy
- 9.8. Natera Inc.
- 9.8.1. Overview
- 9.8.2. Financial Overview
- 9.8.3. Product Offerings
- 9.8.4. Developments
- 9.8.5. Business Strategy
- 9.9. LabCorp
- 9.9.1. Overview
- 9.9.2. Financial Overview
- 9.9.3. Product Offerings
- 9.9.4. Developments
- 9.9.5. Business Strategy
- 9.10. Sema4
- 9.10.1. Overview
- 9.10.2. Financial Overview
- 9.10.3. Product Offerings
- 9.10.4. Developments
- 9.10.5. Business Strategy
- 10. Analyst Opinion
- 11. Annexure
- 11.1. Report Scope
- 11.2. Market Definitions
- 11.3. Research Methodology
- 11.3.1. Data Collation and In-house Estimation
- 11.3.2. Market Triangulation
- 11.3.3. Forecasting
- 11.4. Report Assumptions
- 11.5. Declarations
- 11.6. Stakeholders
- 11.7. Abbreviations
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook